Tag: generic substitution
Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs
Big pharma uses legal loopholes to block cheaper generics by pulling old drugs off shelves just before patents expire. This anticompetitive tactic, called product hopping, costs patients billions - and regulators are finally fighting back.
Why Generic Switching Raises Concerns for NTI Drugs
NTI drugs like warfarin and phenytoin have a tiny margin between effective and toxic doses. Generic switching can cause dangerous fluctuations in blood levels, leading to seizures, bleeding, or overdose. Doctors urge caution and patient vigilance.